⌘K

Home/Companies/FNCH

F

FNCH//CIK 0001733257

Finch Therapeutics Group, Inc.

SIC 2836Biological Products, (No Diagnostic Substances)operating

Exchange

OTC

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

Market Data

Dec 31, 9:30 AM ET

$13.49+$0.04 (+0.275%)

FNCH · Last trade

Prev Close

$13.45

Range (28d)

$13.20 – $14.20

Recent Filings

10 items

8-K
Finch Therapeutics Group, Inc.
Oct 21, 7:45 AM ET·0001193125-24-240034
180.1 KB
10-Q
Finch Therapeutics Group, Inc.
Aug 13, 4:16 PM ET·0000950170-24-096246
5.4 MB
8-K
Finch Therapeutics Group, Inc.
Aug 12, 7:30 AM ET·0001193125-24-198362
149.1 KB
8-K
Finch Therapeutics Group, Inc.
May 24, 6:05 AM ET·0001193125-24-146454
149.5 KB
8-K
Finch Therapeutics Group, Inc.
May 17, 4:45 PM ET·0001193125-24-141816
151.2 KB
10-Q
Finch Therapeutics Group, Inc.
May 10, 4:45 PM ET·0000950170-24-057912
4.8 MB
10-K/A
Finch Therapeutics Group, Inc.
Apr 26, 4:57 PM ET·0000950170-24-049269
780.3 KB
8-K
Finch Therapeutics Group, Inc.
Apr 3, 7:30 AM ET·0001193125-24-085435
148.1 KB
144
Finch Therapeutics Group, Inc.
Mar 28, 4:33 PM ET·0001958244-24-001152
5.9 KB
10-K
Finch Therapeutics Group, Inc.
Mar 25, 4:31 PM ET·0000950170-24-035952
10.7 MB

Insiders

10

Tickers

FNCHOTC→

Addresses

business
75 STATE STREET SUITE 100
BOSTON, MA, 02109
mailing
75 STATE STREET SUITE 100
BOSTON, MA, 02109

Related Biological Products, (No Diagnostic Substances) Companies

AERIE PHARMACEUTICALS INC

Cellular Biomedicine Group, Inc.

Coherus Oncology, Inc.

CHRS

Qrons Inc.

Tarsus Pharmaceuticals, Inc.

TARS

Tourmaline Bio, Inc.

TRML

Prime Medicine, Inc.

PRME

View all Biological Products, (No Diagnostic Substances) companies →